Cargando…

Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction

INTRODUCTION: Several works have suggested heightened risk for cardiac events in cocaine users following percutaneous coronary intervention (PCI). Such studies have generally been performed in small, poorly defined samples and have not utilised optimal control groups. We aimed to define the short-te...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ching Wei Russell, Makkiya, Mohammed, Aronow, Wilbert, Spevack, Daniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963151/
https://www.ncbi.nlm.nih.gov/pubmed/32051707
http://dx.doi.org/10.5114/aoms.2020.91287
_version_ 1783488220223242240
author Chen, Ching Wei Russell
Makkiya, Mohammed
Aronow, Wilbert
Spevack, Daniel M.
author_facet Chen, Ching Wei Russell
Makkiya, Mohammed
Aronow, Wilbert
Spevack, Daniel M.
author_sort Chen, Ching Wei Russell
collection PubMed
description INTRODUCTION: Several works have suggested heightened risk for cardiac events in cocaine users following percutaneous coronary intervention (PCI). Such studies have generally been performed in small, poorly defined samples and have not utilised optimal control groups. We aimed to define the short-term risk for death or recurrent myocardial infarction (MI) when PCI was performed for myocardial infarction in subjects presenting with urine toxicology positive for cocaine in relation to subjects testing negative for cocaine use. MATERIAL AND METHODS: Our institutional electronic health record (EHR) was queried for all subjects with urine toxicology performed for cocaine exposure within 5 days before or after having elevated troponin-T assay between 1/1/08 and 12/31/13. Query results were cross-referenced with our institutional cardiology database to identify the sample who had PCI on the same admission as the cocaine test. Subsequent readmission for MI was assessed from the EHR, and deaths were identified from the National Death Index. RESULTS: PCI had been performed in 380 subjects who tested negative for cocaine and 44 subjects who tested positive. In the cocaine-positive group, incidences of death or MI at 30 days and 1 year were 18% and 23%, respectively. Those who tested positive for cocaine had increased odds (odds ratio (OR) = 2.3, 95% confidence interval (CI): 1.0–5.1, p = 0.04) for death or MI at 30 days post PCI, after adjustment for age, sex, prior MI, and comorbidity index. Although the odds for events 1-year post PCI were not increased (OR = 2.0, 95% CI: 0.9–4.3), the p-value approached significance in this small sample (p = 0.09). CONCLUSIONS: This retrospective study suggests that PCI performed in cocaine-associated myocardial infarction comes with a high 30-day and one-year risk. Further prospective studies are needed to better define this risk and to lend insight into better management strategies.
format Online
Article
Text
id pubmed-6963151
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-69631512020-02-12 Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction Chen, Ching Wei Russell Makkiya, Mohammed Aronow, Wilbert Spevack, Daniel M. Arch Med Sci Clinical Research INTRODUCTION: Several works have suggested heightened risk for cardiac events in cocaine users following percutaneous coronary intervention (PCI). Such studies have generally been performed in small, poorly defined samples and have not utilised optimal control groups. We aimed to define the short-term risk for death or recurrent myocardial infarction (MI) when PCI was performed for myocardial infarction in subjects presenting with urine toxicology positive for cocaine in relation to subjects testing negative for cocaine use. MATERIAL AND METHODS: Our institutional electronic health record (EHR) was queried for all subjects with urine toxicology performed for cocaine exposure within 5 days before or after having elevated troponin-T assay between 1/1/08 and 12/31/13. Query results were cross-referenced with our institutional cardiology database to identify the sample who had PCI on the same admission as the cocaine test. Subsequent readmission for MI was assessed from the EHR, and deaths were identified from the National Death Index. RESULTS: PCI had been performed in 380 subjects who tested negative for cocaine and 44 subjects who tested positive. In the cocaine-positive group, incidences of death or MI at 30 days and 1 year were 18% and 23%, respectively. Those who tested positive for cocaine had increased odds (odds ratio (OR) = 2.3, 95% confidence interval (CI): 1.0–5.1, p = 0.04) for death or MI at 30 days post PCI, after adjustment for age, sex, prior MI, and comorbidity index. Although the odds for events 1-year post PCI were not increased (OR = 2.0, 95% CI: 0.9–4.3), the p-value approached significance in this small sample (p = 0.09). CONCLUSIONS: This retrospective study suggests that PCI performed in cocaine-associated myocardial infarction comes with a high 30-day and one-year risk. Further prospective studies are needed to better define this risk and to lend insight into better management strategies. Termedia Publishing House 2019-12-31 /pmc/articles/PMC6963151/ /pubmed/32051707 http://dx.doi.org/10.5114/aoms.2020.91287 Text en Copyright: © 2019 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Clinical Research
Chen, Ching Wei Russell
Makkiya, Mohammed
Aronow, Wilbert
Spevack, Daniel M.
Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
title Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
title_full Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
title_fullStr Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
title_full_unstemmed Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
title_short Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
title_sort heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963151/
https://www.ncbi.nlm.nih.gov/pubmed/32051707
http://dx.doi.org/10.5114/aoms.2020.91287
work_keys_str_mv AT chenchingweirussell heightenedriskofcardiaceventsfollowingpercutaneouscoronaryinterventionforcocaineassociatedmyocardialinfarction
AT makkiyamohammed heightenedriskofcardiaceventsfollowingpercutaneouscoronaryinterventionforcocaineassociatedmyocardialinfarction
AT aronowwilbert heightenedriskofcardiaceventsfollowingpercutaneouscoronaryinterventionforcocaineassociatedmyocardialinfarction
AT spevackdanielm heightenedriskofcardiaceventsfollowingpercutaneouscoronaryinterventionforcocaineassociatedmyocardialinfarction